Cisplatin is a common, powerful chemotherapy agent used for a wide range of cancers such as breast, ovarian and lung, that in a handful of days can also permanently damage or destroy patients' kidneys ...

Chemotherapy and radiation are common treatments for lung cancer. However, immunotherapy may be able to help double a patient's survival, according to a new report. Researchers from New York ...

Adding immunotherapy to chemotherapy before surgery for patients with operable non-small cell lung cancer—the leading cause of cancer deaths worldwide—improved long-term survival overall compared with ...

Washington, DC -- Nicotine is not known to cause cancer, but it can protect cancer cells from some of the most widely used chemotherapy drugs, researchers reported Sunday at a cancer meeting. Srikumar ...

Combining osimertinib with chemotherapy significantly improved overall survival in advanced EGFR-mutated non-small cell lung cancer. The FLAURA2 trial showed a consistent survival benefit and extended ...

Neoadjuvant nivolumab plus chemotherapy significantly improved pathological complete response and event-free survival in patients with resectable non–small-cell lung cancer (NSCLC) in a phase 3 trial.

Trilaciclib significantly reduced chemotherapy-induced myelosuppression in extensive-stage small cell lung cancer, which authors say minimizes the need for supportive care. Administered before ...

Liv Hospital, the pioneer provider of personalized care, relies on the principle that each patient's cancer is different. The team undertakes to target the specific causes of a person's cancer rather ...